Key Ingredients
Voglibose 0.2 mg inhibits intestinal alpha-glucosidase enzymes, slowing carbohydrate digestion and reducing postprandial blood glucose spikes.
Benefits
Controls Post-Meal Blood Sugar
Helps reduce glucose spikes after meals in type 2 diabetes patients.
Supports Overall Glycemic Control
Improves long-term blood sugar management when combined with diet and exercise.
Non-Insulin Antidiabetic Therapy
Works locally in the intestine without stimulating insulin release.
Reduces Risk of Diabetic Complications
Helps maintain stable glucose levels to support metabolic health.
Well-Established Antidiabetic Agent
Widely used under medical supervision in diabetes care.
Usage Instructions
Take the tablet exactly as prescribed by a healthcare professional, usually just before meals. Regular monitoring of blood glucose levels is recommended.
Side Effects
Take the tablet exactly as prescribed by a healthcare professional, usually just before meals. Regular monitoring of blood glucose levels is recommended.
General Information
- Form: Tablet
- Strength: 0.2 mg
- Composition: Voglibose 0.2 mg
- Brand: VOLIBUS 0.2 TAB
- Packaging Size: 1 × 10 × 10 Tablets
- Packaging Type: Alu-Alu
- Shelf Life: 24 Months
- Indications: Type 2 diabetes mellitus
- Prescription Status: Prescription Drug
- Availability: In Stock
- Country of Origin: India
- Also Available As: PCD Pharma Franchise
Globus Labs brings you WHO-GMP–certified, high-quality Voglibose Tablets IP 0.2 mg sourced from reputed pharmaceutical manufacturers. VOLIBUS 0.2 TAB is formulated to deliver safe, potent, and clinically trusted support.
